![](https://i0.wp.com/gastrolat.org/wp-content/uploads/2023/03/Feature2-17.jpg?resize=326%2C245&ssl=1)
Volumen 32
Atezolizumab y bevacizumab en carcinoma hepatocelular irresecable
Gastroenterol. latinoam. Vol. 32 Num. 1 pp. 24-32 […]
Gastroenterol. latinoam. Vol. 32 Num. 1 pp. 24-32 […]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes